Role of temporal discounting in a conditional cash transfer (CCT) intervention to improve engagement in the prevention of mother-to-child transmission (PMTCT) cascade

Jessica Londeree Saleska, Abigail Norris Turner, Maria F Gallo, Abigail Shoben, Bienvenu Kawende, Noro Lantoniaina Rosa Ravelomanana, Harsha Thirumurthy, Marcel Yotebieng, Jessica Londeree Saleska, Abigail Norris Turner, Maria F Gallo, Abigail Shoben, Bienvenu Kawende, Noro Lantoniaina Rosa Ravelomanana, Harsha Thirumurthy, Marcel Yotebieng

Abstract

Background: Temporal discounting, the tendency of individuals to discount future costs and benefits relative to the present, is often associated with greater engagement in risky behaviors. Incentives such as conditional cash transfers (CCTs) have the potential to counter the effects of high discount rates on health behaviors.

Methods: With data from a randomized trial of a CCT intervention among 434 HIV-positive pregnant women in the Democratic Republic of Congo, we used binomial models to assess interactions between discount rates (measured using a delay-discounting task) and the intervention. The analysis focused on two outcomes: 1) retention in HIV care, and 2) uptake of prevention of mother-to-child transmission (PMTCT) services.

Results: The effect of high discount rates on retention was small, and we did not observe evidence of interaction between high discount rates and CCT on retention. However, our findings suggest that CCT may mitigate the negative effect of high discount rates on uptake of PMTCT services (interaction contrast (IC): 0.18, 95% CI: - 0.09, 0.44).

Conclusions: Our findings provide evidence to support the continued use of small, frequent incentives, to motivate improved uptake of PMTCT services, especially among women exhibiting high rates of temporal discounting.

Trial registration: Clinicaltrials.gov number NCT01838005 , April 23, 2013.

Keywords: HIV; Intertemporal preferences; PMTCT Cascade; Prevention of mother-to-child transmission of HIV (PMTCT); Temporal discounting.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Fowler MG, et al. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med. 2016;375(18):1726–1737. doi: 10.1056/NEJMoa1511691.
    1. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet (London, England) 2002;359(9323):2097–2104. doi: 10.1016/S0140-6736(02)08909-2.
    1. UNAIDS, “Global HIV & AIDS statistics — 2019 fact sheet,” 2019. (Accessed 23 Oct 2019).
    1. S. M. Stricker et al., “Retention in care and adherence to ART are critical elements of HIV care interventions.,” AIDS Behav., vol. 18 Suppl 5, no. S5, pp. S465–S475, 2014, doi: 10.1007/s10461-013-0598-6.
    1. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems’ performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2010;00(0):1–4. doi: 10.1097/QAI.0b013e3181fdbf20.
    1. Sibanda EL, Weller IVD, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care. Aids. 2013;27(17):2787–2797. doi: 10.1097/QAD.0000000000000027.
    1. Fox MP, et al. 2015 Progress report on the global plan. PLoS One. 2016;11(1):18–20. doi: 10.1371/journal.pone.0152672.
    1. Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV care after pregnancy among women in sub-Saharan Africa: falling off the cliff of the treatment cascade. Curr HIV/AIDS Rep. 2015;12(1):1–5. doi: 10.1007/s11904-014-0252-6.
    1. Knettel BA, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era. JAIDS J Acquir Immune Defic Syndr. 2018;77(5):427–438. doi: 10.1097/QAI.0000000000001616.
    1. Gumede-Moyo S, Filteau S, Munthali T, Todd J, Musonda P. Implementation effectiveness of revised (post-2010) World Health Organization guidelines on prevention of mother-to-child transmission of HIV using routinely collected data in sub-Saharan Africa: a systematic literature review. Medicine (Baltimore) 2017;96(40):1–12. doi: 10.1097/MD.0000000000008055.
    1. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis. Medicine (Baltimore) 2016;95(15):e3361. doi: 10.1097/MD.0000000000003361.
    1. C. L. Wallis, C. Godfrey, J. E. Fitzgibbon, and J. W. Mellors, “Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries,” J Infect Dis., vol. 216, no. suppl_9, pp. S851–S856, 2017, doi: 10.1093/infdis/jix409.
    1. Bertagnolio S, et al. Determinants of HIV drug resistance and public health implications in low- and middle-income countries. Antivir Ther. 2012;17(6):941–953. doi: 10.3851/IMP2320.
    1. Lathrop E, Jamieson DJ, Danel I. HIV and maternal mortality. Int J Gynaecol Obstet. 2014;127(2):213–215. doi: 10.1016/j.ijgo.2014.05.024.
    1. Linnemayr S, Rice T. Insights from behavioral economics to design more effective incentives for improving chronic health behaviors, with an application to adherence to Antiretrovirals. JAIDS J Acquir Immune Defic Syndr. 2016;72(2):e50–e52. doi: 10.1097/QAI.0000000000000972.
    1. Taylor NK, Buttenheim AM. Improving utilization of and retention in PMTCT services: Can behavioral economics help? BMC Health Serv Res. 2013;13(1):406. doi: 10.1186/1472-6963-13-406.
    1. Bassett IV, et al. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2016;10(6):451–463. doi: 10.1097/COH.0000000000000196.Financial.
    1. Operario D, Kuo CC, Sosa-Rubí SG, Gálarraga O. Conditional economic incentives for reducing HIV risk behaviors: integration of psychology and behavioral economics. Health Psychol. 2013;32(9):932–940. doi: 10.1037/a0032760.
    1. Mwamba C, et al. ‘They care rudely!’: Resourcing and relational health system factors that influence retention in care for people living with HIV in Zambia. BMJ Glob Health. 2018;3:1007. doi: 10.1136/bmjgh-2018-001007.
    1. A. Fiszbein and N. R. Schady, “Conditional cash transfers: A World Bank Policy Report,” Washington, D.C.: World Bank; 2009. Accessed 07 Aug 2017. Available: .
    1. S. Frederick, G. Loewenstein, and T. O Donoghue, “Time Discounting and Time Preference: A Critical Review,” J Econ Lit., 2002, Accessed: 28 May 2018. Available: .
    1. Yotebieng M, et al. Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic. JAIDS J Acquir Immune Defic Syndr. 2016;74(2):1. doi: 10.1097/QAI.0000000000001219.
    1. Swann M. AIDS care psychological and socio-medical aspects of AIDS/HIV economic strengthening for retention in HIV care and adherence to antiretroviral therapy: a review of the evidence economic strengthening for retention in HIV care and adherence to antiretrovir. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018;30(3):99–125. doi: 10.1080/09540121.2018.1479030org/10.1080/09540121.2018.1479030.
    1. McCoy SI, et al. Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania. Aids. 2017;31(6):815–825. doi: 10.1097/QAD.0000000000001406.
    1. Yotebieng M, et al. Conditional cash transfers to increase retention in PMTCT care, antiretroviral adherence, and postpartum Virological suppression. JAIDS J Acquir Immune Defic Syndr. 2016;72:S124–S129. doi: 10.1097/QAI.0000000000001062.
    1. Solomon SS, et al. Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India. Clin Infect Dis. 2014;59(4):589–595. doi: 10.1093/cid/ciu324.
    1. Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–896. doi: 10.1016/j.amjmed.2012.01.003.
    1. Rosen MI, et al. Improved adherence with contingency management. AIDS Patient Care STDs. 2007;21(1):30–40. doi: 10.1089/apc.2006.0028.
    1. Sorensen JL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88(1):54–63. doi: 10.1016/j.drugalcdep.2006.09.019.
    1. M. O. Rigsby et al., “Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention.,” J Gen Intern Med., vol. 15, no. 12, pp. 841–847 2000, Accessed: 07 Aug 2017. Available: .
    1. Galárraga O, Genberg BL, Martin RA, Laws MB, Wilson IB. Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations. AIDS Behav. 2013;17(7):2283–2292. doi: 10.1007/s10461-013-0415-2.
    1. Yotebieng M, et al. Conditional cash transfers increase uptake of and retention in PMTCT care: a randomized controlled trial. Lancet HIV. 2016;3(2):e85–e93. doi: 10.1016/S2352-3018(15)00247-7.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. L.-W. Chao, H. Szrek, N. S. Pereira, and M. V Pauly, “Time preference and its relationship with age, health, and survival probability.,” Judgm Decis Mak., vol. 4, no. 1, pp. 1–19 2009, Accessed: 03 May 2017. Available: .
    1. Haushofer J, Fehr E. On the psychology of poverty. Science. 2014:862–7.
    1. Sozou PD, Seymour RM. Augmented discounting: interaction between ageing and time-preference behaviour. Proc R Soc B Biol Sci. 2003;270(1519):1047–1053. doi: 10.1098/rspb.2003.2344.
    1. Ahmed A. Rationality and Future Discounting. Topoi. 1(0123456789):1–12. 10.1007/s11245-018-9539-3.
    1. Linnemayr S, Stecher C. Behavioral economics matters for HIV research: the impact of behavioral biases on adherence to Antiretrovirals (ARVs) AIDS Behav. 2015;19(11):2069–2075. doi: 10.1007/s10461-015-1076-0.
    1. Thirumurthy H, et al. Time Preferences Predict Mortality among HIV-Infected Adults Receiving Antiretroviral Therapy in Kenya. PLoS One. 2015;10(12):e0145245. doi: 10.1371/journal.pone.0145245.
    1. Hamilton E, et al. Using the PMTCT Cascade to accelerate achievement of the global plan goals. JAIDS J Acquir Immune Defic Syndr. 2017;75:S27–S35. doi: 10.1097/QAI.0000000000001325.
    1. Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M. ‘If I have nothing to eat, I get angry and push the pills bottle away from me’: a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013;25(10):1271–1277. doi: 10.1080/09540121.2013.764391.
    1. Mupenda B, et al. Terms used for people living with HIV in the Democratic Republic of the Congo. Qual Health Res. 2014;24(2):209–216. doi: 10.1177/1049732313519869.
    1. Puchalski Ritchie LM, et al. What interventions are effective in improving uptake and retention of HIV-positive pregnant and breastfeeding women and their infants in prevention of mother to child transmission care programmes in low-income and middle-income countries? A systematic review and meta-analysis. BMJ Open. 2019;9(7). 10.1136/bmjopen-2018-024907.
    1. Omonaiye O, Nicholson P, Kusljic S, Manias E. A meta-analysis of effectiveness of interventions to improve adherence in pregnant women receiving antiretroviral therapy in sub-Saharan Africa. Int J Infect Dis. 2018;74:71–82. doi: 10.1016/j.ijid.2018.07.004.
    1. Kibaara C, et al. Treatment buddies improve clinic attendance among women but not men on antiretroviral therapy in the Nyanza region of Kenya. AIDS Res Treat. 2016;2016. 10.1155/2016/9124541.
    1. Burks S, Carpenter J, Götte L, Rustichini A. Which measures of time preference best predict outcomes: Evidence from a large-scale field experiment. J Econ Behav. 2012;5808 Available: .
    1. Laibson D. Golden eggs and hyperbolic discounting. Q J Econ. 1997;112(2):443–477. doi: 10.1162/003355397555253.
    1. O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103–124. doi: 10.1257/aer.89.1.103.
    1. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
    1. Esopo K, et al. Measuring self-efficacy, executive function, and temporal discounting in Kenya. Behav Res Ther. 2018;101:30–45. doi: 10.1016/j.brat.2017.10.002.
    1. Carvalho L, Meier S, Wang S. Poverty and economic decision-making: evidence from changes in financial resources at payday. Am Econ Rev. 2016;106(2):260–84.
    1. R. Cassidy, G. Rasool, T. Khan, and H. Zaman, “Are the poor really so present-biased? Experimental evidence from Pakistan,” Inst Fisc Stud., vol. 18, no. 24, 2017, Accessed: 10 Nov 2018. Available: .
    1. Mukumbang FC, Van Belle S, Marchal B, van Wyk B. Exploring ‘generative mechanisms’ of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories. BMC Public Health. 2017;17(1):385. doi: 10.1186/s12889-017-4322-8.
    1. National Institutes of Health (NIH), “Science of Behavior Change,” 2018. (Accessed 10 Nov 2018).

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel